These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25879650)

  • 1. Increased disease due to Haemophilus influenzae type b: population-based surveillance in eastern Gambia, 2008-2013.
    Mackenzie GA; Ikumapayi UN; Scott S; Idoko O; Odutola A; Ndiaye M; Sahito SM; Osuorah CD; Manjang A; Jarju S; Bojang A; Roca A; Secka O; Zaman A; Ceesay L; Lowe-Jallow Y; Sambou S; Jasseh M; Antonio M; Greenwood B; Kampmann B; Mulholland K; Corrah T; Howie SR
    Pediatr Infect Dis J; 2015 May; 34(5):e107-12. PubMed ID: 25879650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction.
    Howie SR; Oluwalana C; Secka O; Scott S; Ideh RC; Ebruke BE; Balloch A; Sambou S; Erskine J; Lowe Y; Corrah T; Adegbola RA
    Clin Infect Dis; 2013 Dec; 57(11):1527-34. PubMed ID: 24046305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of routine vaccination against
    Zaman SM; Howie SR; Ochoge M; Secka O; Bah A; Baldeh I; Sanneh B; Darboe S; Ceesay B; Camara HB; Mawas F; Ndiaye M; Hossain I; Salaudeen R; Bojang K; Ceesay S; Sowe D; Hossain MJ; Mulholland K; Kwambana-Adams BA; Okoi C; Badjie S; Ceesay L; Mwenda JM; Cohen AL; Agocs M; Mihigo R; Bottomley C; Antonio M; Mackenzie GA
    J Glob Health; 2020 Jun; 10(1):010416. PubMed ID: 32509291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Haemophilus influenzae type b disease in The Gambia 14 years after introduction of routine Haemophilus influenzae type b conjugate vaccine immunization.
    Oluwalana C; Howie SR; Secka O; Ideh RC; Ebruke B; Sambou S; Erskine J; Lowe Y; Corrah T; Adegbola RA
    J Pediatr; 2013 Jul; 163(1 Suppl):S4-7. PubMed ID: 23773593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction.
    Sigaúque B; Vubil D; Sozinho A; Quintó L; Morais L; Sacoor C; Carvalho MG; Verani JR; Alonso PL; Roca A
    J Pediatr; 2013 Jul; 163(1 Suppl):S19-24. PubMed ID: 23773589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
    Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
    Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
    Adegbola RA; Secka O; Lahai G; Lloyd-Evans N; Njie A; Usen S; Oluwalana C; Obaro S; Weber M; Corrah T; Mulholland K; McAdam K; Greenwood B; Milligan PJ
    Lancet; 2005 Jul 9-15; 366(9480):144-50. PubMed ID: 16005337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.
    Cowgill KD; Ndiritu M; Nyiro J; Slack MP; Chiphatsi S; Ismail A; Kamau T; Mwangi I; English M; Newton CR; Feikin DR; Scott JA
    JAMA; 2006 Aug; 296(6):671-8. PubMed ID: 16896110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-emergence of Haemophilus influenzae type b (Hib) disease in The Gambia following successful elimination with conjugate Hib vaccine.
    Howie SR; Antonio M; Akisanya A; Sambou S; Hakeem I; Secka O; Adegbola RA
    Vaccine; 2007 Aug; 25(34):6305-9. PubMed ID: 17630053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
    Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.
    Schmitt HJ; von Kries R; Hassenpflug B; Hermann M; Siedler A; Niessing W; Clemens R; Weil J
    Pediatr Infect Dis J; 2001 Aug; 20(8):767-74. PubMed ID: 11734739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against Haemophilus influenzae type b in The Gambia: investigating the extent of protection across age groups.
    Idoko OT; Roberts E; Cox M; Jafali J; Njie-Jobe J; Mackenzie G; Ota MO; Kampmann B
    Vaccine; 2014 Aug; 32(36):4620-4. PubMed ID: 24975810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Fogarty J; Moloney AC; Ramsay ME; Moxon ER
    Pediatr Infect Dis J; 2001 Mar; 20(3):300-5. PubMed ID: 11303834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination?
    Collins S; Ramsay M; Campbell H; Slack MP; Ladhani SN
    Clin Infect Dis; 2013 Dec; 57(12):1715-21. PubMed ID: 24076970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.
    Ladhani S; Ramsay M; Flood J; Campbell H; Slack M; Pebody R; Findlow J; Newton E; Wilding M; Warrington R; Crawford H; Min S; Gray K; Martin S; Frankland S; Bokuvha N; Laher G; Borrow R
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine.
    Sow SO; Diallo S; Campbell JD; Tapia MD; Keita T; Keita MM; Murray P; Kotloff KL; Levine MM
    Pediatr Infect Dis J; 2005 Jun; 24(6):533-7. PubMed ID: 15933564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa.
    von Gottberg A; de Gouveia L; Madhi SA; du Plessis M; Quan V; Soma K; Huebner R; Flannery B; Schuchat A; Klugman K
    Bull World Health Organ; 2006 Oct; 84(10):811-8. PubMed ID: 17128361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali.
    Hutter J; Pasetti MF; Sanogo D; Tapia MD; Sow SO; Levine MM
    Am J Trop Med Hyg; 2012 Jun; 86(6):1026-31. PubMed ID: 22665612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Bowen-Morris J; Griffiths H; Ramsay ME; Deeks JJ; Moxon ER
    JAMA; 2000 Nov; 284(18):2334-40. PubMed ID: 11066183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.